Pacific Edge eyes final US milestone within year

Pacific Edge eyes final US milestone within year
Gavin Evans
By Gavin Evans Aug 1 (BusinessDesk) - Pacific Edge says it may achieve the key third element for reimbursement by private and public US health insurers for its Cxbladder cancer diagnostic tests within a year. The firm has already been granted a national price for its tests and two of its products have been granted national product codes for the US. Studies of Cxbladder published in European Urology and the New Zealand Medical Journal this year, and the products’ inclusion this month in the US National Comprehensive Cancer Network Guide...

More Services

$1.65b project to simplify switching banks a 'flop'
Finance

$1.65b project to simplify switching banks a 'flop'

Open banking has hindered competition rather than helping it, says lobby.

AAP 04 Jul 2024
Hundreds of ECE centres backtracking on pay parity
Policy

Hundreds of ECE centres backtracking on pay parity

96% of daycares have opted into pay parity, but govt funding doesn't match the costs.

Demand pricing may be coming to a movie theatre near you
Markets

Demand pricing may be coming to a movie theatre near you

NZX-listed Vista is rolling out a suite of AI innovations.

Govt 'will consult' on NZ Post review, minister says
Services

Govt 'will consult' on NZ Post review, minister says

The deadline for a review of the postal service is up this month.

Maria Slade 14 Jun 2024